These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27847622)

  • 1. Clinical application of genetic testing for posterior uveal melanoma.
    Schopper VJ; Correa ZM
    Int J Retina Vitreous; 2016; 2():4. PubMed ID: 27847622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma.
    Klufas MA; Richter E; Itty S; Moreno C; McCannel CA; McCannel TA
    Ocul Oncol Pathol; 2017 Dec; 4(1):16-20. PubMed ID: 29344493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of Bad Prognosis in Uveal Melanoma.
    Shao YF; Echegaray JJ; Singh N; Singh AD
    Ophthalmol Retina; 2019 Feb; 3(2):186-193. PubMed ID: 31014770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
    Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
    Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
    Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
    Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
    Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
    Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification.
    Damato B; Dopierala JA; Coupland SE
    Clin Cancer Res; 2010 Dec; 16(24):6083-92. PubMed ID: 20975103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
    Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic techniques used in uveal melanoma: a literature review].
    Abi-Ayad N; Kodjikian L; Couturier J
    J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Metastatic Rates in GEP Class 1A versus 1B Posterior Uveal Melanoma: Results Contrary to Expectations.
    Augsburger JJ; Skinner CC; Correa ZM
    Ocul Oncol Pathol; 2023 Feb; 8(4-6):242-249. PubMed ID: 36925732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Prognosis in Uveal Melanoma.
    Correa ZM
    Cancer Control; 2016 Apr; 23(2):93-8. PubMed ID: 27218785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
    Lake SL; Coupland SE; Taktak AF; Damato BE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
    Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
    JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in the molecular understanding of uveal melanoma.
    Reichstein D
    Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.